Investments
35Portfolio Exits
5Funds
3Partners & Customers
2About Arkin Holdings
Arkin Holdings is a home type organization offering a distinctive combination of practical pharmaceutical knowledge, wide acquaintance with the market along with significant financial capabilities. Arkin Holdings focuses on managing its own financial portfolio and contributing to the R&D and growth of its holding companies.

Want to inform investors similar to Arkin Holdings about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Arkin Holdings News
Jan 30, 2023
Israeli startup Pigmentum is jumping into the no-cow milk space, saying its gene-modified plant-based technology is able to create milk proteins from lettuce that are just like the real thing and can be used to make cheese. Founded in 2018 by Tal Lutzky, who serves as CEO, and Amir Tyroler, who is the COO, the startup recently announced that it had raised $6 million from a seed round led by a group of investors that includes Kibbutz Yotvata, an Israeli venture capital firm Arkin Holdings, American and Israeli family offices, and other private investors. Kibbutz Yotvata and local food giant Strauss group jointly own Yotvata Dairy, one of the largest producers of dairy products in Israel. Existing investors such as Israeli food company Tnuva, local beverage company Tempo, and Israeli VC company OurCrowd also participated in the round. Based in Kiryat Shmona in Israel’s north, Pigmentum says its technology can recreate nature-identical, animal-free versions of milk proteins for the production of dairy duplicates. The startup has developed a mechanism to genetically modify the components of plants using lettuce as a host, which is then irrigated or sprayed with a special fertilizer. Once the crop is harvested, the lettuce is squeezed to yield a juice that is mixed with natural ingredients for taste and smell to mimic a milk-like drink. Publication date:
Arkin Holdings Investments
35 Investments
Arkin Holdings has made 35 investments. Their latest investment was in Pigmentum as part of their Seed VC on January 1, 2023.

Arkin Holdings Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
1/25/2023 | Seed VC | Pigmentum | $6M | Yes | Arkin Holdings, Kibbutz Yotvata, OurCrowd, Tempo, Tnuva Foods, Undisclosed Angel Investors, and Undisclosed Private Equity Investors | 2 |
1/12/2023 | Series A | Welcome Homes | $29M | No | 4 | |
7/21/2022 | Series B | Virility Medical | $10M | No | 4 | |
7/14/2022 | Corporate Minority | |||||
7/6/2022 | Series A |
Date | 1/25/2023 | 1/12/2023 | 7/21/2022 | 7/14/2022 | 7/6/2022 |
---|---|---|---|---|---|
Round | Seed VC | Series A | Series B | Corporate Minority | Series A |
Company | Pigmentum | Welcome Homes | Virility Medical | ||
Amount | $6M | $29M | $10M | ||
New? | Yes | No | No | ||
Co-Investors | Arkin Holdings, Kibbutz Yotvata, OurCrowd, Tempo, Tnuva Foods, Undisclosed Angel Investors, and Undisclosed Private Equity Investors | ||||
Sources | 2 | 4 | 4 |
Arkin Holdings Portfolio Exits
5 Portfolio Exits
Arkin Holdings has 5 portfolio exits. Their latest portfolio exit was Redpin Therapeutics on November 16, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
11/16/2022 | Acquired | 12 | |||
Date | 11/16/2022 | ||||
---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 12 |
Arkin Holdings Fund History
3 Fund Histories
Arkin Holdings has 3 funds, including Arkin Holdings Biotech Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
10/27/2021 | Arkin Holdings Biotech Fund | $270M | 1 | ||
6/14/2016 | Biomed Investment Fund | ||||
Arkin Bio-Ventures II |
Closing Date | 10/27/2021 | 6/14/2016 | |
---|---|---|---|
Fund | Arkin Holdings Biotech Fund | Biomed Investment Fund | Arkin Bio-Ventures II |
Fund Type | |||
Status | |||
Amount | $270M | ||
Sources | 1 |
Arkin Holdings Partners & Customers
2 Partners and customers
Arkin Holdings has 2 strategic partners and customers. Arkin Holdings recently partnered with Phoenix Group on June 6, 2016.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
6/16/2016 | Partner | Italy | Arkin Holdings and Phoenix Group launch $60 mln joint venture HERZLIYA , Israel , June 16 , 2016 / PRNewswire / -- Phoenix Group , one of Israel 's largest Insurance and Finance Companies , and Arkin Holdings , an investment entity specializing in the life science field , today announced a Strategic Collaboration Agreement for investment in pharma and biotech companies , for a total of approximately $ 60 Million . | 3 | |
4/21/2014 | Licensor |
Date | 6/16/2016 | 4/21/2014 |
---|---|---|
Type | Partner | Licensor |
Business Partner | ||
Country | Italy | |
News Snippet | Arkin Holdings and Phoenix Group launch $60 mln joint venture HERZLIYA , Israel , June 16 , 2016 / PRNewswire / -- Phoenix Group , one of Israel 's largest Insurance and Finance Companies , and Arkin Holdings , an investment entity specializing in the life science field , today announced a Strategic Collaboration Agreement for investment in pharma and biotech companies , for a total of approximately $ 60 Million . | |
Sources | 3 |
Arkin Holdings Team
3 Team Members
Arkin Holdings has 3 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
Mori Arkin | Founder | Current | |
Name | Mori Arkin | ||
---|---|---|---|
Work History | |||
Title | Founder | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.